Expect GlaxoSmithKline’s Dividend To Expand Into The 5% Range
moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click here to view […]
NVS
GlaxoSmithKline: Bringing Focus To The Business
moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click here to view […]
Novartis drug Signifor® LAR shows superior efficacy in acromegaly patients not controlled on first generation somatostatin analogues
[PR Newswire] – EAST HANOVER, N.J., May 5, 2014 /PRNewswire/ — Novartis today presented results from a pivotal Phase III trial of investigational therapy Signifor ® LAR (pasireotide LAR; SOM230) in patients with acromegaly … moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click here to […]
[video] What to Watch Monday, May 5: Earnings From Drug Giant Pfizer
moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click here to view […]
Novartis – Outstanding Strategic Initiatives Rendering The Sluggish Growth Irrelevant
moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click here to view […]
Novartis Earnings: What Investors Need to Know
moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click here to view […]
5 companies likely to be here in 100 years
moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click here to view […]
Meet Lung Cancer’s New Enemy
moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click here to view […]
4:51 pm Novartis AG confirms FDA approval for Zykadia, first therapy for patients with ALK+ NSCLC previously treated with the ALK inhibitor crizotinib
moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click here to view […]
Data on Novartis’ Onbrez Breezhaler
moreView todays social media effects on NVSView the latest stocks trending across Twitter. Click to view dashboardSee who Novartis is hiring next, click here to view […]
